|
1
|
Northway WH Jr, Rosan RC and Porter DY:
Pulmonary disease following respirator therapy of hyaline-membrane
disease. Bronchopulmonary dysplasia. N Engl J Med. 276:357–368.
1967. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jobe AH: The new bronchopulmonary
dysplasia. Curr Opin Pediatr. 23:167–172. 2011. View Article : Google Scholar
|
|
3
|
Gien J and Kinsella JP: Pathogenesis and
treatment of bronchopulmonary dysplasia. Curr Opin Pediatr.
23:305–313. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hayes D Jr, Feola DJ, Murphy BS, Shook LA
and Ballard HO: Pathogenesis of bronchopulmonary dysplasia.
Respiration. 79:425–436. 2010. View Article : Google Scholar
|
|
5
|
Tang JR, Markham NE, Lin YJ, et al:
Inhaled nitric oxide attenuates pulmonary hypertension and improves
lung growth in infant rats after neonatal treatment with a VEGF
receptor inhibitor. Am J Physiol Lung Cell Mol Physiol.
287:L344–L351. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Foidart JM, Schaaps JP, Chantraine F, et
al: Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and
sEndoglin) in preeclampsia: a step forward but not the definitive
answer. J Reprod Immunol. 82:106–111. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Speer CP: Chorioamnionitis, postnatal
factors and proinflammatory response in the pathogenetic sequence
of bronchopulmonary dysplasia. Neonatology. 95:353–361. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Soll RF: Corticosteroids for the treatment
and prevention of bronchopulmonary dysplasia. Neonatology.
98:109–110. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jensen EA and Schmidt B: Epidemiology of
bronchopulmonary dysplasia. Birth Defects Res A Clin Mol Teratol.
100:145–157. 2014. View Article : Google Scholar
|
|
10
|
Xu D, Perez RE, Ekekezie II, Navarro A and
Truog WE: Epidermal growth factor-like domain 7 protects
endothelial cells from hyperoxia-induced cell death. Am J Physiol
Lung Cell Mol Physiol. 294:L17–L23. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Asikainen TM and White CW: Pulmonary
antioxidant defenses in the preterm newborn with respiratory
distress and bronchopulmonary dysplasia in evolution: implications
for antioxidant therapy. Antioxid Redox Signal. 6:155–167. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Welty SE: Antioxidants and oxidations in
bronchopulmonary dysplasia: there are no easy answers. J Pediatr.
143:697–698. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Welty SE and Smith CV: Rationale for
antioxidant therapy in premature infants to prevent
bronchopulmonary dysplasia. Nutr Rev. 59:10–17. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chu Chu, Qi Lian-Wen, Liu E-Hu, Li Bin,
Gao Wen and Li Ping: Radix Astragali (Astragalus):
latest advancements and trends in chemistry, analysis, pharmacology
and pharmacokinetics. Curr Org Chem. 14:1792–1807. 2010. View Article : Google Scholar
|
|
15
|
Yang ZG, Sun HX and Fang WH: Haemolytic
activities and adjuvant effect of Astragalus membranaceus
saponins (AMS) on the immune responses to ovalbumin in mice.
Vaccine. 23:5196–5203. 2005.PubMed/NCBI
|
|
16
|
Xu XL, Ji H, Gu SY, Shao Q, Huang QJ and
Cheng YP: Cardioprotective effects of Astragali Radix
against isoproterenol-induced myocardial injury in rats and its
possible mechanism. Phytother Res. 22:389–394. 2008.
|
|
17
|
Ohkawara S, Okuma Y, Uehara T, Yamagishi T
and Nomura Y: Astrapterocarpan isolated from Astragalus
membranaceus inhibits proliferation of vascular smooth muscle
cells. Eur J Pharmacol. 525:41–47. 2005.
|
|
18
|
Yan F, Zhang QY, Jiao L, Han T, Zhang H,
Qin LP and Khalid R: Synergistic hepatoprotective effect of
Schisandrae lignans with Astragalus polysaccharides
on chronic liver injury in rats. Phytomedicine. 16:805–813.
2009.
|
|
19
|
Wang S, Li J, Huang H, Gao W, Zhuang C, Li
B, Zhou P and Kong D: Anti-hepatitis B virus activities of
astragaloside IV isolated from radix Astragali. Biol Pharm
Bull. 32:132–135. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mao XQ, Yu F, Wang N, Wu Y, Zou F, Wu K,
Liu M and Ouyang JP: Hypoglycemic effect of polysaccharide enriched
extract of Astragalus membranaceus in diet induced insulin
resistant C57BL/6J mice and its potential mechanism. Phytomedicine.
16:416–425. 2009.PubMed/NCBI
|
|
21
|
Auyeung KK, Cho CH and Ko JK: A novel
anticancer effect of Astragalus saponins: transcriptional
activation of NSAID-activated gene. Int J Cancer. 125:1082–1091.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yu DH, Bao YM, Wei CL and An LJ: Studies
of chemical constituents and their antioxidant activities from
Astragalus mongholicus Bunge. Biomed Environ Sci.
18:297–301. 2005.PubMed/NCBI
|
|
23
|
Choi SI, Heo TR, Min BH, Cui JH, Choi BH
and Park SR: Alleviation of osteoarthritis by
calycosin-7-O-beta-D-glucopyranoside (CG) isolated from
Astragali radix (AR) in rabbit osteoarthritis (OA) model.
Osteoarthritis Cartilage. 15:1086–1092. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Song JZ, Yiu HH, Qiao CF, Han QB and Xu
HX: Chemical comparison and classification of Radix Astragali by
determination of isoflavonoids and astragalosides. J Pharm Biomed
Anal. 47:399–406. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xu DJ, Xia Q, Wang JJ and Wang PP:
Molecular weight and monosaccharide composition of Astragalus
polysaccharides. Molecules. 13:2408–2415. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang WM, Liang YQ and Wang XH:
Antioxidant and anti-inflammatory effects of Astragalus
polysaccharide on EA.hy926 cells. Exp Ther Med. 36:199–203. 201
|
|
27
|
Yang B, Xiao B and Sun T: Antitumor and
immunomodulatory activity of Astragalus membranaceus
polysaccharides in H22 tumor-bearing mice. Int J Biol Macromol.
62:287–290. 2013.
|
|
28
|
Robbesom AA, Versteeg EM, Veerkamp JH, et
al: Morphological quantification of emphysema in small human lung
specimens: comparison of methods and relation with clinical data.
Mod Pathol. 16:1–7. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Morcillo EJ, Estrela J and Cortijo J:
Oxidative stress and pulmonary inflammation: pharmacological
intervention with antioxidants. Pharmacol Res. 40:393–404. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
D’Angio CT and Maniscalco WM: The role of
vascular growth factors in hyperoxia-induced injury to the
developing lung. Front Biosci. 7:D1609–D1623. 2002.PubMed/NCBI
|
|
32
|
Coalson JJ, Winter VT, Siler-Khodr T and
Yoder BA: Neonatal chronic lung disease in extremely immature
baboons. Am J Respir Crit Care Med. 160:1333–1346. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Krasteva I, Nikolova I, Danchev N and
Nikolov S: Phytochemical analysis of ethyl acetate extract from
Astragalus corniculatus Bieb. and brain antihypoxic
activity. Acta Pharm. 54:151–156. 2004.
|
|
34
|
Bhatt AJ, Pryhuber GS, Huyck H, Watkins
RH, Metlay LA and Maniscalco WM: Disrupted pulmonary vasculature
and decreased vascular endothelial growth factor, Flt-1, and TIE-2
in human infants dying with bronchopulmonary dysplasia. Am J Respir
Crit Care Med. 164:1971–1980. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Soncin F, Mattot V, Lionneton F, Spruyt N,
Lepretre F, Begue A and Stehelin D: VE-statin, an endothelial
repressor of smooth muscle cell migration. EMBO J. 22:5700–5711.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Campagnolo L, Leahy A, Chitnis S,
Koschnick S, Fitch MJ, Fallon JT, Loskutoff D, Taubman MB and
Stuhlmann H: EGFL7 is a chemoattractant for endothelial cells and
is up-regulated in angiogenesis and arterial injury. Am J Pathol.
167:275–284. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
De Maziere A, Parker L, Van Dijk S, Ye W
and Klumperman J: Egfl7 knockdown causes defects in the extension
and junctional arrangements of endothelial cells during zebrafish
vasculogenesis. Dev Dyn. 237:580–591. 2008.PubMed/NCBI
|
|
38
|
Parker LH, Schmidt M, Jin SW, et al: The
endothelial-cell-derived secreted factor Egfl7 regulates
vascular tube formation. Nature. 428:754–758. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hockenbery DM, Oltvai ZN, Yin XM, Milliman
CL and Korsmeyer SJ: Bcl-2 functions in an antioxidant pathway to
prevent apoptosis. Cell. 75:241–251. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Oltval ZN, Milliman CL and Korsmeyer SJ:
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that
accelerates programed cell death. Cell. 74:609–619. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kroon AA and Post M: Apoptotic cell death
in bronchopulmonary dysplasia. Curr Pediatr Rev. 7:285–292. 2011.
View Article : Google Scholar
|
|
42
|
Schmidt M, Paes K, De Maziere A, et al:
EGFL7 regulates the collective migration of endothelial cells by
restricting their spatial distribution. Development. 134:2913–2923.
2007. View Article : Google Scholar : PubMed/NCBI
|
